Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. - Wikidata - awgldk - TriplyDB

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

http://www.wikidata.org/entity/Q30383368

about

Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs Vitamin D and influenza Acute respiratory distress syndrome induced by a swine 2009 H1N1 variant in mice Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients Two years after pandemic influenza A/2009/H1N1: what have we learned?Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.Pulmonary immune responses to 2009 pandemic influenza A (H1N1) virus in mice.Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection.Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines.Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.Cytokine profiles of suction pulmonary secretions from children infected with pandemic influenza A(H1N1) 2009 Host response to influenza virus: protection versus immunopathology.Host adaptive immunity deficiency in severe pandemic influenza.Severe pandemic (H1N1)v influenza A infection: report on the first deaths in Spain.Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients Clinical aspects and cytokine response in severe H1N1 influenza A virus infection Development of adenoviral vector-based mucosal vaccine against influenza.Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection.The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation.The impact of sex, gender and pregnancy on 2009 H1N1 disease Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.Comparison of pandemic (H1N1) 2009 and seasonal influenza viral loads, Singapore.Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection.Novel influenza A (H1N1) infection vs. common influenza-like illness: a prospective study Pandemic 2009 H1N1 virus infection associated with purpuric skin lesions: a case report Influenza 2009 pandemic: Cellular immunemediated surveillance modulated by TH17 & Tregs.The first influenza pandemic of the new millennium.Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection.Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.

P2860

Q21090975-CE352D3E-0A5F-4060-8428-DE81B16A98AA Q21285123-D8D3B1D9-AA5F-4F57-B626-6D5ACB26159F Q24339361-1004E88D-906A-4521-8180-9FB4DCE57B86 Q24629018-9AEBACC7-D2E6-4854-B4E9-3FDF607673DB Q26800158-B5404934-A07A-424E-8B31-1E9625F205CE Q26830578-CC2FC17A-E1BD-4883-93EE-D939F1AD5CE8 Q27310762-6D55381C-F6E9-4B56-B0B4-20627965207B Q27315823-6A21B84C-6737-4F8D-9268-A0F8B32A60AE Q28476579-C06CF7BF-6343-499A-BB12-3414F861F253 Q28741451-58E2513B-9CAA-4A67-B60B-01F01A9C9D53 Q30224656-5473DD6C-98F2-4C47-B68C-CA743EFC5484 Q30352743-B577479F-827B-4C69-AA54-871BA7E06ABD Q30360402-AE442DAD-3014-42A0-B596-722A33A5B260 Q30361309-0A396069-56C8-4AA0-BFA9-791811A48D06 Q30361318-9A355355-A17A-42F2-9798-2509F462902C Q30366138-4B2D39AB-2CE9-43C0-BC57-8A14D113FFF4 Q30367153-D086856F-33F6-4E4C-96E7-9569FF3BA46E Q30381864-F9AEF8FE-24AF-4F1E-8920-CF4F48553933 Q30386775-415407E7-CBA7-4511-BC65-DBE1F1A7564F Q30388494-F6E9CF49-0A57-45A7-B315-35CB0D7BB447 Q30391010-AD90CEB4-E8B3-4AB0-89BA-607DD5088819 Q30393612-D5219A5B-556B-427A-96E5-7CCED8FDF6A5 Q30394861-F1162F36-024B-40D0-B821-1161CF7AD289 Q30395003-4605E05B-B518-4A59-86A4-1CB7DA532EBC Q30396035-16523BD9-039B-4DA6-AC87-11488E965DF5 Q30396642-1D7C666A-70BD-4C5A-B1B4-3DE885AB79EF Q30396672-228395FF-37E6-47B3-8205-AD311184E608 Q30396915-71CBDB52-EB9B-4103-A9E8-14D3E53E17BA Q30398193-D2DD14E5-6751-4BD1-A78C-8BEA91B1E3ED Q30398612-1AD2F1A1-716C-423C-8386-B83EC68C0988 Q30399323-ECB40DE2-F7BD-49AE-B893-DE53D641914B Q30399952-CE6C4388-7A47-41A6-907C-21DD84F74905 Q30401338-D82608BC-8535-4D91-BF30-B2C0E91848A2 Q30401370-A8D1CB1B-27DF-46D1-935B-4CF77AA9E31B Q30401513-CB9DBCE6-783C-431A-8992-68A70336ADA9 Q30401658-F6246374-AAA7-4A98-A629-6A47108E5804 Q30403278-05135B91-6D55-4C15-9F24-AB9E139487F6 Q30403288-BACE05B3-A06D-418F-8E37-C2316317053F Q30404138-AC9E3BDA-CA84-4B3D-96C1-AB5529496D3D Q30404361-3284D2F1-388B-4E84-9D86-4B4CF4A7B6AA

P2860

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

http://www.wikidata.org/entity/Q30383368

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@ast

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@en

type

label

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@ast

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@en

prefLabel

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@ast

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@en

P1433

Q30383368-2D59D825-31A7-47EE-9F88-984DE7B67624

P1476

Q30383368-99D3CC50-1CB7-4B44-9E74-D6ACAAA78D02

P2093

Q30383368-01090AD2-99AD-4A65-A96B-460B4E0AAE63

Q30383368-039F4A2A-9028-48CC-8DC0-203CAE0ADEB4

Q30383368-03DE32BB-D75D-400B-BE31-3FE23F34800C

Q30383368-1D2F8AE4-9837-443C-BCCC-0873CE0EEE40

Q30383368-291BB85F-A166-43E6-82E9-4F6F4163F39A

Q30383368-2FC8B46A-4626-4206-AB77-A788674BDD2E

Q30383368-35B1F3BC-50DF-4F20-B510-9CEE91325A97

Q30383368-36E362D9-1D9D-4F37-8265-4C57376DE7E8

Q30383368-3D11E223-F069-4D91-86D4-E719039DBA09

Q30383368-4A91B8F4-9E57-491B-99C9-EB4299FB6F6E

P2860

Q30383368-0C5A8D02-36B6-44BC-98FF-66D25E3D4905

Q30383368-0D40334B-7CB4-4498-95EF-418B05A4C9A9

Q30383368-0FB8A8BC-E540-4931-A63A-46A73373B67B

Q30383368-1D796444-4AF1-4090-8446-0BFA9063A7DE

Q30383368-244AEFD5-F3AC-43D4-8131-800D16A25C5D

Q30383368-2E7C1429-1A13-47C7-AE1E-9BF062C95A54

Q30383368-346269C7-C4CF-4B0C-B7AF-E4382EF8A6FC

Q30383368-37B49C2D-F48B-484B-98CF-0C8FC9A3F317

Q30383368-38373DCD-10A5-4B0C-AADF-C871547B41F5

Q30383368-432DCE68-FD12-48AF-B313-5F2F6066E5E1

P2888

Q30383368-69E81B78-0BD3-40C3-8C05-FE6DBA353379

P304

Q30383368-ABED3150-C900-4C50-803E-D6198CBB24E0

P31

Q30383368-BBFBF10A-0C1B-435A-95E2-6802788B7758

P356

Q30383368-6EEA7D30-4D12-4E58-B7EF-1E4770F1F867

P433

Q30383368-AA248A5C-A8B5-4D2B-9E9D-873CDF0008BA

P478

Q30383368-51839929-0BCD-487D-AF3D-BC8847F197FB

P50

Q30383368-6BED872A-E1A4-4369-828E-621F6F787C53

Q30383368-8CA4591B-1C03-458C-9B57-193E75D434B9

Q30383368-ADC022A6-5B50-4AF5-9D4C-0EC46C096687

Q30383368-BBED1EBE-3F6D-47B7-8304-9F60A61A98D8

Q30383368-FEFE1025-8F94-43D7-858B-54142A908D01

P577

Q30383368-3FCD3277-BF24-409F-AFCA-35BF573B0D12

P5875

Q30383368-4AAA754B-2A02-42A0-AE75-5D697544E3ED

P6179

Q30383368-898E13EE-354A-43D7-9E77-84664B46F844

P698

Q30383368-947040D2-7FF6-4CAD-9918-641005E491EA

P921

Q30383368-FFAD3259-F784-4BBA-915A-C4F3A56C3B45

P932

Q30383368-55748DC0-03BD-433D-AC53-C53A42F409C5

P356

P1433

P1476

Th1 and Th17 hypercytokinemia ...... in severe pandemic influenza.

@en

P2093

Alberto Del Castillo

http://www.w3.org/2001/XMLSchema#string

Alberto Leon

http://www.w3.org/2001/XMLSchema#string

Alberto Tenorio-Abreu

http://www.w3.org/2001/XMLSchema#string

Aurora Lietor

http://www.w3.org/2001/XMLSchema#string

Beatriz Villanueva

http://www.w3.org/2001/XMLSchema#string

Carlos Javier López

http://www.w3.org/2001/XMLSchema#string

Carlos Serón

http://www.w3.org/2001/XMLSchema#string

Carmen Hinojosa

http://www.w3.org/2001/XMLSchema#string

Dariela Micheloud

http://www.w3.org/2001/XMLSchema#string

David Banner

http://www.w3.org/2001/XMLSchema#string

P2860

IL-17 and Th17 Cells

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Confronting an influenza pandemic with inexpensive generic agents: can it be done?

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

H1N1 influenza, public health preparedness, and health care reform.

Protective immunity to influenza: lessons from the virus for successful vaccine design.

Severe respiratory disease concurrent with the circulation of H1N1 influenza.

Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices.

P2888

P304

R201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC8208

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Tomàs Pumarola Suñe

Jesus F Bermejo-Martin

P577

2009-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40681217

http://www.w3.org/2001/XMLSchema#string

P6179

1012038777

http://www.w3.org/2001/XMLSchema#string

P698

20003352

http://www.w3.org/2001/XMLSchema#string

P921

P932

2811892

http://www.w3.org/2001/XMLSchema#string